At the time of writing, Boston Scientific Corp. [BSX] stock is trading at $81.79, up 1.39%. An important factor to consider is whether the stock is rising or falling in short-term value. The BSX shares have gain 3.31% over the last week, with a monthly amount glided 8.82%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Boston Scientific Corp. [NYSE: BSX] stock has seen the most recent analyst activity on May 30, 2024, when Goldman initiated its Buy rating and assigned the stock a price target of $90. Previously, Mizuho upgraded its rating to Buy on February 01, 2024, and elevated its price target to $80. On July 19, 2023, Robert W. Baird initiated with a Outperform rating and assigned a price target of $59 on the stock. CL King started tracking the stock assigning a Buy rating and suggested a price target of $64 on June 30, 2023. UBS started tracking with a Buy rating for this stock on March 29, 2023, and assigned it a price target of $57. In a note dated December 22, 2022, Mizuho initiated an Neutral rating and provided a target price of $52 on this stock.
For the past year, the stock price of Boston Scientific Corp. fluctuated between $48.35 and $80.96. Currently, Wall Street analysts expect the stock to reach $70.19 within the next 12 months. Boston Scientific Corp. [NYSE: BSX] shares were valued at $81.79 at the most recent close of the market. An investor can expect a potential drop of -14.18% based on the average BSX price forecast.
Analyzing the BSX fundamentals
According to Boston Scientific Corp. [NYSE:BSX], the company’s sales were 15.23B for trailing twelve months, which represents an 14.48% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.52.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.96 points at the first support level, and at 80.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.36, and for the 2nd resistance point, it is at 82.92.
Ratios To Look Out For
It is important to note that Boston Scientific Corp. [NYSE:BSX] has a current ratio of 1.61. On the other hand, the Quick Ratio is 1.14, and the Cash Ratio is 0.54. Considering the valuation of this stock, the price to sales ratio is 7.91, the price to book ratio is 5.91 and price to earnings (TTM) ratio is 66.17.
Transactions by insiders
Recent insider trading involved Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology, that happened on Aug 28 ’24 when 14132.0 shares were sold. Officer, JOSEPH M FITZGERALD completed a deal on Aug 28 ’24 to buy 14132.0 shares. Meanwhile, EVP& Grp Pres, MedSurg & APAC Butcher Arthur C sold 14012.0 shares on Aug 26 ’24.
